Differential expression and action of Toll-like receptors in human adrenocortical cells

Molecular and Cellular Endocrinology

Volumn 300, Issue 1-2, 2009, Pages 57-65

  Kanczkowski, Waldemar ^a   Zacharowski, Kai ^b   Wirth, Manfred P ^a   Ehrhart Bornstein, Monika ^a   Bornstein, Stefan R ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adrenal insufficiency; Cytokines; Immune adrenal crosstalk; Inflammation; NF B activation; Stress response

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL CORTEX CELL; ADRENAL INSUFFICIENCY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL ACTIVATION; CELL STIMULATION; CONFOCAL MICROSCOPY; GENE ASSIGNMENT; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA ISOLATION; STRESS; TISSUE REGENERATION;

ADRENAL CORTEX; AGED; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NF-KAPPA B; PROTEIN ISOFORMS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59649092527     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.10.028     Document Type: Article

References (30)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Angus D.C., and Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 29 (2001) S109-S116
3. Bornstein S.R., Rutkowski H., and Vrezas I. Cytokines and steroidogenesis. Mol. Cell. Endocrinol. 215 (2004) 135-141
4. Bornstein S.R., Schumann R.R., Rettori V., McCann S.M., and Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36 (2004) 470-473
5. Bornstein S.R., Zacharowski P., Schumann R.R., Barthel A., Tran N., Papewalis C., Rettori V., McCann S.M., Schulze-Osthoff K., Scherbaum W.A., Tarnow J., and Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16695-16700
6. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., and Herman J.P. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 19 (2008) 175-180
7. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332 (1995) 1351-1362
8. Gonzalez-Hernandez J.A., Ehrhart-Bornstein M., Spath-Schwalbe E., Scherbaum W.A., and Bornstein S.R. Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid: evidence for paracrine control of adrenal function. J. Clin. Endocrinol. Metab. 81 (1996) 807-813
9. Harii N., Lewis C.J., Vasko V., McCall K., Avides-Peralta U., Sun X., Ringel M.D., Saji M., Giuliani C., Napolitano G., Goetz D.J., and Kohn L.D. Thyrocytes express a functional Toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol. Endocrinol. 19 (2005) 1231-1250
10. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002) 4531-4537
11. Hotchkiss R.S., and Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348 (2003) 138-150
12. Husebye H., Halaas O., Stenmark H., Tunheim G., Sandanger O., Bogen B., Brech A., Latz E., and Espevik T. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 25 (2006) 683-692
13. Kanczkowski W., Morawietz H., Ziegler C.G., Funk R.H., Schmitz G., Zacharowski K., Mohn C.E., Ehrhart-Bornstein M., and Bornstein S.R. Pam3CSK4 and LTA-TLRs ligands associated with microdomains induce IL8 production in human adrenocortical cancer cells. Horm. Metab. Res. 39 (2007) 457-460
14. Kanczkowski W., Ziegler C.G., Zacharowski K., and Bornstein S.R. Toll-like receptors in endocrine disease and diabetes. Neuroimmunomodulation 15 (2008) 54-60
15. Lotz S., Aga E., Wilde I., van Z.G., Hartung T., Solbach W., and Laskay T. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 75 (2004) 467-477
16. Marx C., Ehrhart-Bornstein M., Scherbaum W.A., and Bornstein S.R. Regulation of adrenocortical function by cytokines-relevance for immune-endocrine interaction. Horm. Metab. Res. 30 (1998) 416-420
17. Medzhitov R. Origin and physiological roles of inflammation. Nature 454 (2008) 428-435
18. Nishimura M., and Naito S. Tissue-specific mRNA expression profiles of human Toll-like receptors and related genes. Biol. Pharm. Bull. 28 (2005) 886-892
19. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 (2006) 3-9
20. Palazzo M., Balsari A., Rossini A., Selleri S., Calcaterra C., Gariboldi S., Zanobbio L., Arnaboldi F., Shirai Y.F., Serrao G., and Rumio C. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J. Immunol. 178 (2007) 4296-4303
21. Path G., Bornstein S.R., Spath-Schwalbe E., and Scherbaum W.A. Direct effects of interleukin-6 on human adrenal cells. Endocr. Res. 22 (1996) 867-873
22. Rainey W.E., Bird I.M., and Mason J.I. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100 (1994) 45-50
23. Romero D.G., Vergara G.R., Zhu Z., Covington G.S., Plonczynski M.W., Yanes L.L., Gomez-Sanchez E.P., and Gomez-Sanchez C.E. Interleukin-8 synthesis, regulation, and steroidogenic role in H295R human adrenocortical cells. Endocrinology 147 (2006) 891-898
24. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
25. Shih M.C., Hsu N.C., Huang C.C., Wu T.S., Lai P.Y., and Chung B.C. Mutation of mouse Cyp11a1 promoter caused tissue-specific reduction of gene expression and blunted stress response without affecting reproduction. Mol. Endocrinol. 22 (2008) 915-923
26. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10 (1994) 405-455
27. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165 (2000) 5392-5396
28. Tran N., Koch A., Berkels R., Boehm O., Zacharowski P.A., Baumgarten G., Knuefermann P., Schott M., Kanczkowski W., Bornstein S.R., Lightman S.L., and Zacharowski K. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J. Clin. Endocrinol. Metab. 92 (2007) 2773-2783
29. Vakharia K., and Hinson J.P. Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenase-dependent mechanism. Endocrinology 146 (2005) 1398-1402
30. Zacharowski K., Zacharowski P.A., Koch A., Baban A., Tran N., Berkels R., Papewalis C., Schulze-Osthoff K., Knuefermann P., Zahringer U., Schumann R.R., Rettori V., McCann S.M., and Bornstein S.R. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6392-6397